Dr. Karl Morten, PhD is the Director of Graduate Studies and Principal Investigator at the Nuffield Department of Women's and Reproductive Health at the University of Oxford. He is the lead researcher on the first research project Lyme Treatment Foundation is funding titled, "New pharmacological agents to treat persistent infections". Learn more about this exciting research project below, or visit his website here:
The Oxford University ME/CFS research group led by Dr. Karl Morten are struggling to find the last £30,000 to run a 3 year PhD project which will recruit new ME/CFS, Long Covid and Chronic Lyme Disease patients for a range of biological assessments.
This funding is required to match a £45,000 grant from Action for ME, otherwise the Action for ME grant will need to be returned. The project explores the link between the gut and tissue microbiome and its association with ME/CFS, Long Covid disease and Chronic Lyme Disease.
This will be the first study to look at all three of these similar conditions in a single project. The total project budget £200,000 includes a $50,000 in kind contribution from SoftCell Biologicals for the sequencing of pathogens and the culturing of persistent" L-Form organisms. Learn more here:
Donations of any size can be given by the Oxford Development ME/CFS research page below.
Your support will enable us to fund innovative research from universities around the world and improve the lives of those battling tick-borne diseases. Make a donation today!
Copyright © 2018 Lyme Treatment Foundation, Inc. - All Rights Reserved.